Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Johnson & Johnson (

How To Use Covered Calls To Get 17% Annualized Return On JNJ Stock

Selling the May 155 call option generates an income of 3.42% in just over two months, equaling around 17% annualized.

Investors Business Daily

Buy the Dip in Johnson & Johnson and Its Near-3% Dividend Yield

Johnson & Johnson stock has fallen in seven straight weeks, trades at less than 15 times earnings and pays a near-3% dividend yield. Plus, support is nearby.

The Street

Hundreds more tech, life science layoffs jolt East Bay, San Francisco

BERKELEY, Calif. — Hundreds more layoffs affecting tech and life science jobs in the Bay Area have been disclosed by companies in what has morphed into a steady drumbeat of local staffing reductions in the wobbly sectors.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Appeals court clears the way for more lawsuits over Johnson's Baby Powder

A U.S. appeals court has dismissed the bankruptcy case filed by a Johnson & Johnson spinoff company. Around 40,000 cancer patients have filed suit, alleging the powder was contaminated with asbestos.

WEKU

Why inventing a vaccine for AIDS is tougher than for COVID

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

WEKU

What on Earth Is Aaron Rodgers Talking About?

The Packers quarterback gets asked about trade rumors, calls out woke culture, Big Pharma.

Sports Illustrated

J&J Stock Jolted by NYSE Glitch, and Earnings Don’t Help. Check the Chart.

Johnson & Johnson stock has fallen in 10 straight sessions and was jolted by NYSE issues and the earnings report. Here's the trade.

The Street

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Falls 200 Points With 8 Key Earnings Movers; Microsoft Earnings Due

The Dow Jones Industrial Average fell 180 points Tuesday as J&J and Verizon reported earnings. Microsoft earnings are due out after the stock market close.

Investors Business Daily

J&J subsidiary to pay $9.75M to resolve kickback allegations

Federal prosecutors say a subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon

The Independent UK

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Investors Business Daily

A guide to purchasing stock in a Fortune 500 company

The steps to purchase a Fortune 500 stock and why they can be a valuable part of your portfolio.

Fortune

The 4 Most Attractive Long-Term Stock Picks

With the Fed expected to keep rates higher throughout this year, the odds of the economy tipping into a recession are rising. Amid ongoing macroeconomic uncertainties, investors may consider buying companies with reliable performance over the years for solid long-term returns. To that end, Pfizer (PFE), Johnson & Johnson (JNJ),…

StockNews.com

The 'Kraken' COVID variant taking hold in the U.S. Here's how many vaccine shots there are—and what experts recommend to protect yourself

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

Fortune

Vaccines are not making COVID strains like 'Kraken' stronger

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Dividend Stock to Buy Now and Retire on Later

Johnson & Johnson (JNJ) continued its business momentum in the third quarter of fiscal 2022, driven by steady demand for its products and innovative, advancing portfolio and pipeline. Moreover, the company has a record of raising its dividend for 60 consecutive years. Amid the current uncertain market conditions, this fundamentally…

The Street

Johnson & Johnson Files for IPO of Consumer Health Division Kenvue

Johnson & Johnson's consumer health care division, named Kenvue, will have annual sales of around $15 billion.

The Street

Stocks Edge Higher, Jobs Data, Amazon, Johnson & Johnson, Walgreen - Five Things To Know

Stock futures flat as Fed minutes challenge rate bets; Jobs data in focus as Fed highlights wage growth; Johnson & Johnson plans IPO for consumer health care division; Amazon confirms 18,000 layoffs as big tech sheds more jobs and Walgreens earnings on deck with pharmacy sales in focus.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

There's A New World Order As 4 Big Stocks Like Tesla Fall To Pieces

Want to see just how much stocks like Tesla have fallen to pieces? Just look at the new top 10 most valuable S&P 500 firms.

Tribune News Service

Getting vaccinated this holiday season? Here’s how to stay up-to-date on your COVID shots

DALLAS — Staying on schedule with the COVID-19 vaccine can feel like chasing a moving target.

Al Jazeera

Ebola vaccines produced lasting antibodies during trial: Studies

Studies in West Africa said the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children.

Reuters

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

Investors Business Daily

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

ABC News

Pelvic mesh victims left unsure of futures as legal fees threaten to slash class action payout

The legal firm representing the thousands of plaintiffs in a class action over dangerous pelvic mesh could take up to a third of the compensation payment.

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 7 8 9 10

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.